Research Topics
| Sodiomon Bienvenu SirimaSummaryAffiliation: Centre National de Recherche et de Formation sur le Paludisme Country: Burkina Faso Publications
| Collaborators
|
Detail Information
Publications
Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina FasoSodiomon Bienvenu Sirima
Centre National de Recherche et de Formation sur le Paludisme, Ministere de la Sante, Ouagadougou, Burkina Faso, West Africa
Trop Med Int Health 8:133-9. 2003....- Population pharmacokinetics of artesunate and amodiaquine in African childrenKasia Stepniewska
Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420 6 Rajvithi Road, Bangkok 10400, Thailand
Malar J 8:200. 2009..The aim of this study was to evaluate the PK properties of a newly developed and registered fixed dose combination (FDC) of artesunate and amodiaquine... - Strict adherence to malaria rapid test results might lead to a neglect of other dangerous diseases: a cost benefit analysis from Burkina FasoZeno Bisoffi
Centre for Tropical Diseases, S, Cuore Hospital, Negrar Verona, Italy
Malar J 10:226. 2011..This paper aims at determining the costs and benefits of two competing strategies for the management of MAF: presumptive treatment for all or use of RDTs... - Wide cross-reactivity between Anopheles gambiae and Anopheles funestus SG6 salivary proteins supports exploitation of gSG6 as a marker of human exposure to major malaria vectors in tropical AfricaCinzia Rizzo
Department of Public Health and Infectious Diseases, Sapienza University, P le Aldo Moro 5, 00185 Rome, Italy
Malar J 10:206. 2011..gambiae species complex whereas the A. funestus homologue, fSG6, is more divergent (80% identity with gSG6). The aim of this study was to evaluate cross-reactivity of human sera to gSG6 and fSG6... - Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimensAlfred B Tiono
Centre National de Recherche et de Formation sur le Paludisme, Ministere de la Sante, Ouagadougou, Burkina Faso
Malar J 8:224. 2009.... - Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysisJulien Zwang
Shoklo Malaria Research Unit, Mae Sot, Thailand
Malar J 8:203. 2009..It was necessary to evaluate the efficacy of ACT, recently adopted by the World Health Organization (WHO) and deployed over 80 countries, in order to make an evidence-based drug policy... - Plasmodium falciparum genotypes diversity in symptomatic malaria of children living in an urban and a rural setting in Burkina FasoIssiaka Soulama
Centre National de Recherche et de Formation sur le Paludisme, 01 BP 2208 Ouagadougou 01, Burkina Faso
Malar J 8:135. 2009..The analysis of the Plasmodium falciparum genetic diversity in children with uncomplicated malaria, living in these two different areas, may help to understand the effect of urbanization on the distribution of P. falciparum genotypes... - Implementation of Home based management of malaria in children reduces the work load for peripheral health facilities in a rural district of Burkina FasoAlfred B Tiono
Centre National de Recherche et de Formation sur Paludisme, Ministère de Santé, Ouagadougou, Burkina Faso, West Africa
Malar J 7:201. 2008..However, the potential fall-out of this community-based strategy on the work burden at the peripheral health facilities level has never been investigated... - Accuracy of a rapid diagnostic test on the diagnosis of malaria infection and of malaria-attributable fever during low and high transmission season in Burkina FasoZeno Bisoffi
Centre for Tropical Diseases, S, Cuore Hospital, 37024 Negrar, Verona, Italy
Malar J 9:192. 2010..This study aims at estimating the accuracy of a RDT for the diagnosis of both malaria infection and malaria - attributable fever, in a region of Burkina Faso with a typically seasonal malaria transmission pattern... - Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe childrenSodiomon B Sirima
Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso
PLoS ONE 4:e7549. 2009..The aim of this study was to assess the safety and immunogenicity of this vaccine candidate in children aged 12-24 months living in malaria endemic area of Burkina Faso... - The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparumSodiomon B Sirima
Centre National de Recherche et de Formation sur le Paludisme CNRFP, BP 2208, Ouagadougou, Burkina Faso
Malar J 8:48. 2009..Artesunate (AS) plus amodiaquine (AQ) is one artemisinin-based combination (ACT) recommended by the WHO for treating Plasmodium falciparum malaria. Fixed-dose AS/AQ is new, but its safety and efficacy are hitherto untested... - Efficacy of artesunate plus chloroquine for the treatment of uncomplicated malaria in children in Burkina Faso: a double-blind, randomized, controlled trialSodiomon Bienvenu Sirima
Centre National de Recherche et de Formation sur le Paludisme, Ministere de la Sante, 01 B P 2028, Ouagadougou 01, Burkina Faso
Trans R Soc Trop Med Hyg 97:345-9. 2003..Despite the beneficial effects of adding AS, the high failure rate at day 28 of CQ-AS precludes its use as the first-line regimen for treating CQ-resistant P. falciparum in Burkina Faso... - Artesunate-amodiaquine for the treatment of uncomplicated malariaSodiomon Bienvenu Sirima
Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou 01, Burkina Faso
Expert Opin Investig Drugs 16:1079-85. 2007..A prequalification dossier of this fixed combination has been submitted to the WHO. This new co-formulation will almost certainly increase its effectiveness by improving drug compliance... - Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West AfricaSodiomon B Sirima
Centre National de Recherche et de Formation sur le Paludisme CNRFP, 01 BP 2208 Ouagadougou 01, Burkina Faso
Vaccine 25:2723-32. 2007..We report here the first data on the safety, reactogenicity and immunogenicity of three doses of MSP3-LSP, adjuvanted with aluminium hydroxide, in healthy male adults living in a malaria endemic area... - Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina FasoSodiomon B Sirima
Centre National de Recherche et de Formation sur le Paludisme, , Ouagadougou, Burkina Faso
Am J Trop Med Hyg 75:205-11. 2006..66, P < 0.0001 and RR = 0.71, P = 0.0002, respectively). These data suggest that a package of IPTp/SP and ITNs is effective in reducing the burden of malaria during pregnancy in Burkina Faso... - Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupéla District, Burkina FasoSodiomon B Sirima
Centre National de Recherche et de Formation sur le Paludisme, , Ouagadougou
Clin Infect Dis 36:1374-82. 2003..Alternative prevention strategies, such as use of insecticide-treated mosquito nets and intermittent preventive treatment with more-effective antimalarials, are needed... - Low-high season variation in Plasmodium falciparum erythrocyte binding antigen 175 (eba-175) allelic forms in malaria endemic area of Burkina FasoIssiaka Soulama
Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso
Trop Med Int Health 15:51-9. 2010..To assess the impact of seasonal variation on the distribution of the eba-175 allelic forms in the area where malaria transmission is markedly seasonal... - Naturally Acquired Immune Responses to Plasmodium falciparum Sexual Stage Antigens Pfs48/45 and Pfs230 in an Area of Seasonal TransmissionAndré Lin Ouédraogo
Centre National de Recherche et de Formation sur le Paludisme, Rue de l Oubritenga 1487, Ouagadougou BP 2208, Burkina Faso
Infect Immun 79:4957-64. 2011..001). Our findings suggest that naturally acquired immunity against Pfs48/45 and Pfs230 is a function of recent exposure rather than of cumulative exposure to gametocytes... - Genetic diversity of polymorphic vaccine candidate antigens (apical membrane antigen-1, merozoite surface protein-3, and erythrocyte binding antigen-175) in Plasmodium falciparum isolates from western and central AfricaIssiaka Soulama
Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso
Am J Trop Med Hyg 84:276-84. 2011.... - Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West AfricaIssa Nebie
CNRFP, 01 BP 2208, Ouagadougou 01, Burkina Faso
Infect Immun 76:759-66. 2008..Currently included in malaria vaccine formulations for clinical trials in humans, these blood-stage antigens, AMA1 and GLURP, offer good prospects for malaria vaccine development... - Antiplasmodial activity and toxicity of crude extracts from alternatives parts of plants widely used for the treatment of malaria in Burkina Faso: contribution for their preservationAdama Gansane
Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, 01 POB 2208, Ouagadougou 01, Burkina Faso
Parasitol Res 106:335-40. 2010..The data generated clearly show that the trunk bark for Z. zanthoxyloides and the leaves for A. leiocarpus and C. molle could be used for the treatment of malaria instead of roots and stem bark... - Temporal dynamics of malaria transmission in two rural areas of Burkina Faso with two ecological differencesEdith Ilboudo-Sanogo
Centre National de Recherche et de Formation sur le Paludisme, 01 BP 2208 Ouagadougou 01, Burkina Faso
J Med Entomol 47:618-24. 2010..These results have confirmed the marked seasonality of malaria transmission in the study area...